These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11720444)

  • 21. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
    Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
    Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of squamous cell cancers of the vulvar anterior fourchette by human papillomavirus, p16INK4a, and p53.
    Reuschenbach M; Roos J; Panayotopoulos D; Baldus SE; Schnürch HG; Berger A; Petry KU; Dürst M; Seiz M; von Knebel Doeberitz M; Hampl M;
    J Low Genit Tract Dis; 2013 Jul; 17(3):289-97. PubMed ID: 23645067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AKT1 loss correlates with episomal HPV16 in vulval intraepithelial neoplasia.
    Ekeowa-Anderson AL; Purdie KJ; Gibbon K; Byrne CR; Arbeit JM; Harwood CA; O'Shaughnessy RF
    PLoS One; 2012; 7(6):e38608. PubMed ID: 22685591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p73 in normal skin and proliferative skin lesions.
    Kamiya M; Takeuchi Y; Katho M; Yokoo H; Sasaki A; Nakazato Y
    Pathol Int; 2004 Dec; 54(12):890-5. PubMed ID: 15598310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
    Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
    Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.
    Zwahlen D; Tschan MP; Grob TJ; Peters UR; Fink D; Haenggi W; Altermatt HJ; Cajot JF; Tobler A; Fey MF; Aebi S
    Int J Cancer; 2000 Oct; 88(1):66-70. PubMed ID: 10962441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
    Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
    Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
    Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
    Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas.
    Matsha T; Donninger H; Erasmus RT; Hendricks D; Stepien A; Parker MI
    Virology; 2007 Dec; 369(1):182-90. PubMed ID: 17761206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
    Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
    Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
    Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
    Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
    Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
    Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of p16INK4a correlates with high expression of p73 in breast carcinomas.
    Garcia V; Silva J; Dominguez G; García JM; Peña C; Rodriguez R; Provencio M; España P; Bonilla F
    Mutat Res; 2004 Oct; 554(1-2):215-21. PubMed ID: 15450420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.